Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma

Cancer Immunology, Immunotherapy : CII
Roger Gilabert-OriolPeter J Wookey

Abstract

We have reported that calcitonin receptor (CTR) is widely expressed in biopsies from the lethal brain tumour glioblastoma by malignant glioma and brain tumour-initiating cells (glioma stem cells) using anti-human CTR antibodies. A monoclonal antibody against an epitope within the extracellular domain of CTR was raised (mAb2C4) and chemically conjugated to either plant ribosome-inactivating proteins (RIPs) dianthin-30 or gelonin, or the drug monomethyl auristatin E (MMAE), and purified. In the high-grade glioma cell line (HGG, representing glioma stem cells) SB2b, in the presence of the triterpene glycoside SO1861, the EC50 for mAb2C4:dianthin was 10.0 pM and for mAb2C4:MMAE [antibody drug conjugate (ADC)] 2.5 nM, 250-fold less potent. With the cell line U87MG, in the presence of SO1861, the EC50 for mAb2C4:dianthin was 20 pM, mAb2C4:gelonin, 20 pM, compared to the ADC (6.3 nM), which is >300 less potent. Several other HGG cell lines that express CTR were tested and the efficacies of mAb2C4:RIP (dianthin or gelonin) were similar. Co-administration of the enhancer SO1861 purified from plants enhances lysosomal escape. Enhancement with SO1861 increased potency of the immunotoxin (>3 log values) compared to the ADC (1 log). The upt...Continue Reading

References

Sep 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J J BodyA Borkowski
Nov 1, 1987·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G C NicholsonT J Martin
Jun 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M G RosenblumL Cheung
Jul 14, 1995·Journal of Molecular Biology·M V HosurK K Kannan
Dec 17, 1997·International Journal of Cancer. Journal International Du Cancer·M T GillespieD M Findlay
Mar 24, 1998·Thyroid : Official Journal of the American Thyroid Association·J L FrendoA Jullienne
Jul 25, 2000·Biochemical and Biophysical Research Communications·C JaggerM Pondel
Nov 2, 2001·Nature·T ReyaI L Weissman
Jan 1, 2003·The Journal of Comparative Neurology·Mary TolcosPeter Wookey
Jan 18, 2003·The Journal of Biological Chemistry·Thomas SeckWilliam C Horne
Feb 1, 2003·Lancet·Anthony BehinJean-Yves Delattre
Mar 13, 2003·Kidney International·Christos TikellisPeter J Wookey
Jul 2, 2003·Acta Crystallographica. Section D, Biological Crystallography·Simona FermaniFiorenzo Stirpe
Jun 1, 2005·Experimental Cell Research·Elena I Fomchenko, Eric C Holland
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jan 30, 2008·Current Opinion in Cell Biology·Jennifer L RossDavid M Warshaw
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Oct 16, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander WengHendrik Fuchs
Sep 3, 2013·Cell Death and Differentiation·A DickinsonJ C St John
Sep 27, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Amanda TivnanKerrie L McDonald
Oct 18, 2013·The New England Journal of Medicine·Sunit Das, Philip A Marsden
Nov 20, 2014·Nature·Avinashnarayan VenkatanarayanElsa R Flores
Feb 5, 2015·Journal of Neuro-oncology·Abdel Nasser HoseinJennifer H Martin
Mar 12, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander WengStephen L Hart
Jun 28, 2015·Biologicals : Journal of the International Association of Biological Standardization·Gregory S Hamilton
Mar 11, 2016·Current Opinion in Immunology·Bart Ecg de Goeij, John M Lambert
Mar 22, 2016·Scientific Reports·Thomas James GrundyGeraldine Margaret O'Neill
Oct 22, 2016·Cell·Sebastian George Barton FurnessPatrick Michael Sexton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.